SCHEMBL7940518

SCHEMBL7940518

CCCOc1ccccc1-c1nc(Cl)cc(Cl)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 11/20 0.46
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46
PDE4C Q08493 2/20 0.46
PDE4D Q08499 2/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
ATM Q13315 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
CYP1A2 P05177 2/20 0.44
CYP19A1 P11511 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
GCGR P47871 1/20 0.44
MAPK14 Q16539 1/20 0.44
TLR8 Q9NR97 1/20 0.43
PTGER1 P34995 1/20 0.43
KMT2A Q03164 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404281 0.90 MAPT (0.46) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL28131881 0.87 PDE5A (0.52) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL7939339 0.81 ALDH1A1 (0.51) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL10756097 0.81 LTA4H (0.43) MAPTALDH1A1LMNAHTTATM
SCHEMBL28928070 0.78 CYP1A2 (0.62) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL17292882 0.78 CYP1A2 (0.62) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL29365709 0.78 CYP1A2 (0.62) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL10646200 0.78 HSP90AA1 (0.59) ALDH1A1LMNATDP1CYP1A2CYP2C19
SCHEMBL8387581 0.77 IDO1 (0.43) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL10438816 0.77 HTR7 (0.53) PDE5APDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239136-B1 REGULATING APOPTOSIS IN HUMAN CELLS HAVING AUTOIMMUNE DISEASE CELL PATHWAYS, INC. 2001-05-29 US disclosed
US-5874440-A ADMINISTERING TO THE PATIENT HAVING PRECANCEROUS LESIONS TO INHIBIT GROWTH OF NEOPLASTIC CELLS CELL PATHWAYS, INC. (US) 1999-02-23 US disclosed
US-5118686-A Administering bronchodilator agents for respiratory disorders SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1992-06-02 US disclosed
EP-0395328-A2 Penylpyrimidone derivates and their use as therapeutic agents SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-10-31 EP disclosed